Does NIVOLUMAB\RELATLIMAB-RMBW Cause Off label use? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Off label use have been filed in association with NIVOLUMAB\RELATLIMAB-RMBW. This represents 9.2% of all adverse event reports for NIVOLUMAB\RELATLIMAB-RMBW.
46
Reports of Off label use with NIVOLUMAB\RELATLIMAB-RMBW
9.2%
of all NIVOLUMAB\RELATLIMAB-RMBW reports
13
Deaths
8
Hospitalizations
How Dangerous Is Off label use From NIVOLUMAB\RELATLIMAB-RMBW?
Of the 46 reports, 13 (28.3%) resulted in death, 8 (17.4%) required hospitalization, and 1 (2.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB\RELATLIMAB-RMBW. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB\RELATLIMAB-RMBW Cause?
Death (82)
Malignant neoplasm progression (35)
Myocarditis (21)
Rash (18)
Adverse event (14)
Product storage error (13)
Colitis (12)
Dyspnoea (12)
Fatigue (12)
Immune-mediated myocarditis (12)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which NIVOLUMAB\RELATLIMAB-RMBW Alternatives Have Lower Off label use Risk?
NIVOLUMAB\RELATLIMAB-RMBW vs NIZATIDINE
NIVOLUMAB\RELATLIMAB-RMBW vs NOMEGESTROL
NIVOLUMAB\RELATLIMAB-RMBW vs NORDAZEPAM
NIVOLUMAB\RELATLIMAB-RMBW vs NOREPINEPHRINE
NIVOLUMAB\RELATLIMAB-RMBW vs NOREPINEPHRINE\NOREPINEPHRINE